Medicine

The illegal substance—paired with intensive therapy and hard work—dramatically improves PTSD symptoms

Hopes were high for drugs designed to lower levels of a mutant protein, but development has stalled

The development from the Biden administration draws cheers from public health researchers and ire from drugmakers

The new DNA-based test predicts transplant rejection

Clear messaging and transparency are vital, say some experts on risk assessment and decision-making

Next-generation COVID-19 vaccines will not only tackle different versions of the virus but will provide solutions across the world at a fraction of the cost

Preliminary results suggest the vaccine is up to 77 percent effective in young children, but researchers await larger studies

It was lysozyme, an enzyme that attacks the cell walls of bacteria—and just as with the celebrated antibiotic, he found it through pure serendipity

Infectious disease physician-scientist Wilbur Chen discusses the rare cases of blood clots linked to the immunization

For the first time, a randomized controlled trial shows the psychedelic offers potent, if short-term, relief in comparison with an SSRI

An infectious disease doctor answers questions about the CDC’s and FDA’s decision to pause the vaccine’s use over a possible link with blood clots

Researchers are searching for possible links between unusual clotting and the Oxford-AstraZeneca coronavirus vaccine